Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to -$1.1 million.

  • Coya Therapeutics' Free Cash Flow rose 7929.81% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.1 million, marking a year-over-year decrease of 1997.81%. This contributed to the annual value of -$10.3 million for FY2024, which is 804.37% up from last year.
  • Latest data reveals that Coya Therapeutics reported Free Cash Flow of -$1.1 million as of Q3 2025, which was up 7929.81% from -$5.8 million recorded in Q2 2025.
  • Over the past 5 years, Coya Therapeutics' Free Cash Flow peaked at $2.1 million during Q1 2024, and registered a low of -$5.8 million during Q2 2025.
  • Its 4-year average for Free Cash Flow is -$2.6 million, with a median of -$2.2 million in 2023.
  • Per our database at Business Quant, Coya Therapeutics' Free Cash Flow skyrocketed by 15553.9% in 2024 and then crashed by 23180.06% in 2025.
  • Over the past 4 years, Coya Therapeutics' Free Cash Flow (Quarter) stood at -$2.2 million in 2022, then fell by 0.81% to -$2.2 million in 2023, then fell by 7.53% to -$2.4 million in 2024, then surged by 53.08% to -$1.1 million in 2025.
  • Its Free Cash Flow was -$1.1 million in Q3 2025, compared to -$5.8 million in Q2 2025 and -$2.8 million in Q1 2025.